• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】22231

【品名】4-Bromobenzaldehyde

【CA登记号】1122-91-4

【 分 子 式 】C7H5BrO

【 分 子 量 】185.0201

【元素组成】C 45.44% H 2.72% Br 43.19% O 8.65%

与该中间体有关的原料药合成路线共 10 条

合成路线1

该中间体在本合成路线中的序号:(I)

After protection of 4-bromobenzaldehyde (I) with triethyl orthoformate in MeOH, the resultant bromo ketal (II) was converted to the corresponding Grignard reagent (III) with magnesium in THF. Conjugate addition of (III) to the steroid epoxide (IV) in the presence of CuCl gave rise to the 11-beta-aryl steroid (V). Introduction of a 17-spiro oxirane moiety into ketone (V) to yield (VI) was accomplished by reaction with the sulfur ylide generated from trimethylsulfonium iodide and potassium tert-butoxide. Subsequent epoxide opening in (VI) with NaOMe gave rise to the methoxy alcohol (VII), which was further alkylated with iodomethane under Williamson's ether synthesis conditions to provide the dimethoxy derivative (VIII). Acid hydrolysis of both ketal groups of (VIII) with concomitant alcohol dehydration led to the dienone (IX). The aldehyde function of (IX) was finally converted to the target oxime by treatment with hydroxylamine hydrochloride in pyridine.

1 Schubert, G.; Kaufmann, G.; Sobeck, L.; Oettel, M.; Elger, W.; Kurischko, A. (Jenapharm GmbH); 11-Benzaldoximeestradiene-derivates, a process for their preparation and pharmaceutical compsns. containing them. CA 2130516; DE 4322283; EP 0648778 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(II) 23438 (4-bromophenyl)(methoxy)methyl methyl ether; 1-bromo-4-(dimethoxymethyl)benzene C9H11BrO2 详情 详情
(III) 30851 bromo[4-(dimethoxymethyl)phenyl]magnesium C9H11BrMgO2 详情 详情
(IV) 56197   C20H28O4 详情 详情
(V) 56198 (5R,8S,11R,13S,14S)-11-[4-(dimethoxymethyl)phenyl]-5-hydroxy-3,3-dimethoxy-13-methyl-1,2,3,4,5,6,7,8,11,12,13,14,15,16-tetradecahydro-17H-cyclopenta[a]phenanthren-17-one C29H40O6 详情 详情
(VI) 56199   C30H42O6 详情 详情
(VII) 56200 (8S,11R,13S,14S,17S)-11-[4-(dimethoxymethyl)phenyl]-3,3-dimethoxy-17-(methoxymethyl)-13-methyl-1,2,3,4,6,7,8,11,12,13,14,15,16,17-tetradecahydro-5H-cyclopenta[a]phenanthrene-5,17-diol C31H46O7 详情 详情
(VIII) 56201 (8S,11R,13S,14S,17S)-11-[4-(dimethoxymethyl)phenyl]-3,3,17-trimethoxy-17-(methoxymethyl)-13-methyl-1,2,3,4,6,7,8,11,12,13,14,15,16,17-tetradecahydro-5H-cyclopenta[a]phenanthren-5-ol C32H48O7 详情 详情
(IX) 56202 4-[(8S,11R,13S,14S,17S)-17-methoxy-17-(methoxymethyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-11-yl]benzaldehyde C28H34O4 详情 详情

合成路线2

该中间体在本合成路线中的序号:(I)

1) The reaction of 4-bromobenzaldehyde (I) with trimethylorthoformate (II) and p-toluenesulfonic acid in methanol gives ketal (III), which is condensed with 2-pyridylmagnesium bromide in THF, yielding 4-(2-pyridyl)benzaldehyde (IV). The reaction of (IV) with tert-butyl carbazate (V) in refluxing ethanol affords hydrazone (VI), which is reduced with H2 over Pd/C in methanol to the hydrazine (VII). The condensation of (VII) with the epoxide (VIII) in hot isopropanol gives the expected addition product (IX), which by treatment with HCl or formic acid results in the fully deprotected intermediate (X). Finally, this compound is condensed with N-(methoxycarbonyl)-L-tert-leucine (XI) by means of O-(2-oxo-1,2-dihydro-1-pyridyl)-N,N,N',N'-tetramethyluronium tetrafluoroborate (TPTU) in dichloromethane or DMF.

1 New aza-dipeptide analogues as potent and orally a. J Med Chem 1998, 41, 18, 3387.
2 Fassler, A.; Bold, G.; Capraro, H.-G.; Lang, M.; Khanna, S.C. (Novartis AG); Antivirally active heterocyclic azahexane derivs.. EP 0900210; JP 1999511177; US 5849911; WO 9740029 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(II) 23438 (4-bromophenyl)(methoxy)methyl methyl ether; 1-bromo-4-(dimethoxymethyl)benzene C9H11BrO2 详情 详情
(III) 23439 bromo(2-pyridinylmethyl)magnesium C6H6BrMgN 详情 详情
(IV) 23440 4-(2-pyridinyl)benzaldehyde C12H9NO 详情 详情
(V) 10893 tert-butyl 1-hydrazinecarboxylate; tert-butyl carbazate 870-46-2 C5H12N2O2 详情 详情
(VI) 23442 tert-butyl 2-[(Z)-[4-(2-pyridinyl)phenyl]methylidene]-1-hydrazinecarboxylate C17H19N3O2 详情 详情
(VII) 23443 tert-butyl 2-[4-(2-pyridinyl)benzyl]-1-hydrazinecarboxylate C17H21N3O2 详情 详情
(VIII) 23444 tert-butyl (1S)-1-[(2R)oxiranyl]-2-phenylethylcarbamate C15H21NO3 详情 详情
(IX) 23445 tert-butyl 2-[(2S,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-4-phenylbutyl]-2-[4-(2-pyridinyl)benzyl]-1-hydrazinecarboxylate C32H42N4O5 详情 详情
(X) 23446 (2S,3S)-3-amino-4-phenyl-1-[1-[4-(2-pyridinyl)benzyl]hydrazino]-2-butanol C22H26N4O 详情 详情
(XI) 23447 (2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutyric acid C8H15NO4 详情 详情

合成路线3

该中间体在本合成路线中的序号:(I)

Condensation of 4-bromobenzaldehyde (I) with 4-fluorophenol (II) in the presence of K2CO3 in refluxing dimethylacetamide gave ether (III). Subsequent reductive amination of (III) with cycloheptylamine (IV) using ethanolic NaBH4 afforded secondary amine (V). Phenyl carbamate (VIII) was obtained by treatment of aminopyridine (VI) with phenyl chloroformate (VII) and dimethylaniline. Condensation of this carbamate with amine (V) in the presence of Et3N in refluxing toluene furnished urea (IX) (1). Both sulfide groups of (IX) were finally oxidized to sulfone using meta-chloroperbenzoic acid in CH2Cl2.

1 Tanaka, A.; Terasawa, T.; Hagihara, H.; Ishibe, N.; Sawada, M.; Sakuma, Y.; Hashimoto, M.; Takasugi, H.; Tanaka, H.; Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 3. Discovery of a novel series of N-alkyl-N-[(fluorophenoxy)benzyl]-N'-arylureas with weak toxicological effects on adrenal glands. J Med Chem 1998, 41, 22, 4408.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(II) 19639 4-fluorophenol 371-41-5 C6H5FO 详情 详情
(III) 22233 4-(4-fluorophenoxy)benzaldehyde C13H9FO2 详情 详情
(IV) 22234 cycloheptanamine; cycloheptylamine 5452-35-7 C7H15N 详情 详情
(VI) 22235 N-cycloheptyl-N-[4-(4-fluorophenoxy)benzyl]amine; N-[4-(4-fluorophenoxy)benzyl]cycloheptanamine C20H24FNO 详情 详情
(VI) 22239 6-methyl-2,4-bis(methylsulfanyl)-3-pyridinylamine; 6-methyl-2,4-bis(methylsulfanyl)-3-pyridinamine C8H12N2S2 详情 详情
(VII) 13580 1-[(Chlorocarbonyl)oxy]benzene; phenyl chloroformate 1885-14-9 C7H5ClO2 详情 详情
(VIII) 18000 phenyl 6-methyl-2,4-bis(methylsulfanyl)-3-pyridinylcarbamate C15H16N2O2S2 详情 详情
(IX) 22241 N-cycloheptyl-N-[4-(4-fluorophenoxy)benzyl]-N'-[6-methyl-2,4-bis(methylsulfanyl)-3-pyridinyl]urea C29H34FN3O2S2 详情 详情

合成路线4

该中间体在本合成路线中的序号:(I)

Condensation of 4-bromobenzaldehyde (I) with 4-fluorophenol (II) in the presence of K2CO3 in refluxing dimethylacetamide gave ether (III). Subsequent reductive amination of (III) with cycloheptylamine (IV) using ethanolic NaBH4 afforded secondary amine (V). Phenyl carbamate (VIII) was obtained by treatment of aminopyridine (VI) with phenyl chloroformate (VII) and dimethylaniline. Finally, condensation of this carbamate with amine (V) in the presence of Et3N in DMF at 100 C furnished the target urea.

1 Frank, A.; Karn, H.; Spanig, H. (Abbott GmbH & Co. KG); Production of 1-hydroxyalkyl-5-nitroimidazoles. DE 2359625; FR 2253019; GB 1481349 .
2 Frank, A.; Dockner, T.; Karn, H. (Abbott GmbH & Co. KG); Process for the preparation of 1-(2-hydroxyethyl)-2-methyl-5-nitroimidazole of high purity. EP 0150407 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(II) 19639 4-fluorophenol 371-41-5 C6H5FO 详情 详情
(III) 22233 4-(4-fluorophenoxy)benzaldehyde C13H9FO2 详情 详情
(IV) 22234 cycloheptanamine; cycloheptylamine 5452-35-7 C7H15N 详情 详情
(V) 22235 N-cycloheptyl-N-[4-(4-fluorophenoxy)benzyl]amine; N-[4-(4-fluorophenoxy)benzyl]cycloheptanamine C20H24FNO 详情 详情
(VI) 22236 2,4,6-trimethyl-3-pyridinylamine; 2,4,6-trimethyl-3-pyridinamine C8H12N2 详情 详情
(VII) 13580 1-[(Chlorocarbonyl)oxy]benzene; phenyl chloroformate 1885-14-9 C7H5ClO2 详情 详情
(VIII) 22238 phenyl 2,4,6-trimethyl-3-pyridinylcarbamate C15H16N2O2 详情 详情

合成路线5

该中间体在本合成路线中的序号:(I)

Palladium-catalyzed coupling of 4-bromobenzaldehyde (I) with methyl acrylate (II) furnished methyl 4-formylcinnamate (III). After aldehyde protection as the ethylene acetal (IV), ester group reduction using DIBAL in cold CH2Cl2 gave rise to the cinnamyl alcohol (V). O-Alkylation of (V) with ethyl iodide in the presence of NaH produced the corresponding ethyl ether (VI). The acetal protecting group of (VI) was then hydrolyzed with HCl to yield aldehyde (VII).

2 Zhang, C.; Mjalli, A.M.M. (Ontogen Corp.); Imidazole derivs. as MDR modulators. EP 0999835; US 5840721; WO 9902155 .
1 Dixon, R.; Zhang, C.; Sarshar, S.; Mjalli, A.M.M.; Rodarte, J.C.; Moran, E.J.; Benbatoul, K.D.; Krane, S.; 2,4,5-Trisubstituted imidazoles: Novel nontoxic modulators of P-glycoprotein mediated multidrug resistance. Part 2. Bioorg Med Chem Lett 2000, 10, 23, 2603.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(II) 14156 methyl acrylate 96-33-3 C4H6O2 详情 详情
(III) 46515 methyl (E)-3-(4-formylphenyl)-2-propenoate 7560-50-1 C11H10O3 详情 详情
(IV) 46516 methyl (E)-3-[4-(1,3-dioxolan-2-yl)phenyl]-2-propenoate C13H14O4 详情 详情
(V) 46517 (E)-3-[4-(1,3-dioxolan-2-yl)phenyl]-2-propen-1-ol C12H14O3 详情 详情
(VI) 46518 (E)-3-[4-(1,3-dioxolan-2-yl)phenyl]-2-propenyl ethyl ether; 2-[4-[(E)-3-ethoxy-1-propenyl]phenyl]-1,3-dioxolane C14H18O3 详情 详情
(VII) 46519 4-[(E)-3-ethoxy-1-propenyl]benzaldehyde C12H14O2 详情 详情

合成路线6

该中间体在本合成路线中的序号:(XII)

Suzuki coupling between 4-bromobenzaldehyde (XII) and 4-trifluoromethylbenzeneboronic acid (XIII) produced the biphenyl compound (XIV). The reductive amination of aldehyde (XIV) with N,N-diethyl ethylenediamine (XV) gave diamine (XVI) (1). This was finally coupled with the intermediate carboxylic acid (XI) to afford the title amide.

1 Smith, S.A.; Inhibition of lipoprotein-associated phospholipase A2 - A novel approach for the treatment of atherosclerosis. 11th RSC-SCI Med Chem Symp (Sept 9 2001, Cambridge) 2001, Abst .
2 Ife, R.J.; Leach, C.A.; Smith, S.A.; Pinto, I.L.; Hickey, D.M.B.; Fenwick, A.E. (GlaxoSmithKline plc); Pyrimidinone cpds.. EP 1175408; WO 0066567 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XI) 53050 2-[2-[(4-fluorobenzyl)sulfanyl]-5-[(1-methyl-1H-pyrazol-4-yl)methyl]-4-oxo-1(4H)-pyrimidinyl]acetic acid n/a C18H17FN4O3S 详情 详情
(XII) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(XIII) 48639 4-(Trifluoromethyl)phenylboronic acid C7H6BF3O2 详情 详情
(XIV) 53051 4-[4-(trifluoromethyl)phenyl]benzaldehyde n/a C14H9F3O 详情 详情
(XV) 12420 N-(2-Aminoethyl)-N,N-diethylamine; N,N-Diethylethylene-diamine; N(1),N(1)-Diethyl-1,2-ethanediamine 100-36-7 C6H16N2 详情 详情
(XVI) 53052 N-[2-(diethylamino)ethyl]-N-{[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl}amine; N~1~,N~1~-diethyl-N~2~-{[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl}-1,2-ethanediamine n/a C20H25F3N2 详情 详情

合成路线7

该中间体在本合成路线中的序号:(I)

The cyclization of 4-bromobenzaldehyde (I) with butanedione monooxime (II) by means of HCl in acetic acid gives 2-(4-bromophenyl)-4,5-dimethyloxazole N-oxide (III), which is chlorinated with POCl3 in refluxing chloroform to yield the chloromethyl derivative (IV). The reaction of (IV) with KCN and KI in hot DMF affords the cyanomethyl compound (V), which is hydrolyzed with KOH in water/2-methoxyethanol to provide the acetic acid derivative (VI). The reduction of (VI) with BH3/THF in THF gives the ethanol intermediate (VII), which is condensed with phenylboronic acid (VIII) by means of PPh3 and Pd(OAc)2 in propanol to yield the biphenyl derivative (IX). The reaction of the OH group of (IX) with tosyl anhydride in dichloromethane affords the tosylate (X), which is condensed with 2-(4-hydroxyphenoxy)-2-methylpropionic aid ethyl ester (XI) by means of Cs2CO3 in hot DMF to provide the ethyl ester precursor (XII). Finally, this compound is hydrolyzed with NaOH in methanol/water to obtain the target propionic acid.

1 Brooks, D.A.; et al.; Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2-aryloxazol-4-yl)ethoxy]phenoxy}propionic acids: A new class of dual PPARalpha/gamma agonists. J Med Chem 2001, 44, 13, 2061.
2 Matthews, D.P.; Hay, D.A.; Ardecky, R.J.; Warshawsky, A.M.; Gossett, L.S.; Dominianni, S.J.; Rito, C.J.; Shuker, A.J.; Brooks, D.A.; Michellys, P.-Y.; Tyhonas, J.S. (Eli Lilly and Company; Ligand Pharmaceuticals, Inc.); Biaryl-oxa(thia)zole derivs. and their use as PPARs modulators. EP 1206457; US 6417212; WO 0116120 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(II) 55397 2,3-Butanedione 2-oxime; 2,3-Butanedione monoxime; 2,3-Butanedione oxime; 2,3-Butanedione-2-monoxime; Diacetyl monoxime 57-71-6 C4H7NO2 详情 详情
(III) 55398 2-(4-bromophenyl)-4,5-dimethyl-1,3-oxazol-3-ium-3-olate C11H10BrNO2 详情 详情
(IV) 55399 2-(4-bromophenyl)-4-(chloromethyl)-5-methyl-1,3-oxazole C11H9BrClNO 详情 详情
(V) 55400 2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]acetonitrile C12H9BrN2O 详情 详情
(VI) 55401 2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]acetic acid C12H10BrNO3 详情 详情
(VII) 55402 2-[2-(4-bromophenyl)-5-methyl-1,3-oxazol-4-yl]-1-ethanol C12H12BrNO2 详情 详情
(VIII) 16593 Phenylboronic acid;Benzeneboronic acid;Phenylboron dihydroxide 98-80-6 C6H7BO2 详情 详情
(IX) 55403 2-(2-[1,1'-biphenyl]-4-yl-5-methyl-1,3-oxazol-4-yl)-1-ethanol C18H17NO2 详情 详情
(X) 55404 2-(2-[1,1'-biphenyl]-4-yl-5-methyl-1,3-oxazol-4-yl)ethyl 4-methylbenzenesulfonate C25H23NO4S 详情 详情
(XI) 55405 ethyl 2-(4-hydroxyphenoxy)-2-methylpropanoate C12H16O4 详情 详情
(XII) 55406 ethyl 2-{4-[2-(2-[1,1'-biphenyl]-4-yl-5-methyl-1,3-oxazol-4-yl)ethoxy]phenoxy}-2-methylpropanoate C30H31NO5 详情 详情

合成路线8

该中间体在本合成路线中的序号:(XI)

Suzuki coupling between 4-bromobenzaldehyde (XI) and 4-trifluoromethylbenzeneboronic acid (XII) affords the biphenylyl aldehyde (XIII). This is then reductively aminated with N,N-diethylethylenediamine (XIV) and NaBH4 to produce diamine (XV) (1,3). Finally, coupling between amine (XV) and carboxylic acid (VIII) leads to the title carboxamide

1 The identification of clinical candidate SB-480848: A potent inhibitor of lipoprotein-associated phospholipase A2. Bioorg Med Chem Lett 2003, 13, 6, 1067.
2 Ife, R.J.; Leach, C.A.; Hickey, D.M.B.; Pinto, I.L.; Smith, S.A.; Stanway, S.J. (GlaxoSmithKline plc); Pyrimidine-4-one derivs. as LDL-PLA 2 inhibitors. EP 1263740; JP 2003523335; US 2002103213; US 6649619; WO 0160805 .
3 Mulholland, K.R.; Ross, A.R.; Smith, G.E.; Slater, G.R. (GlaxoSmithKline plc); Novel processes. WO 0316287 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(VIII) 63494 2-(2-{[(4-fluorophenyl)methyl]sulfanyl}-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)acetic acid C16H15FN2O3S 详情 详情
(XI) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(XII) 48639 4-(Trifluoromethyl)phenylboronic acid C7H6BF3O2 详情 详情
(XIII) 53051 4-[4-(trifluoromethyl)phenyl]benzaldehyde n/a C14H9F3O 详情 详情
(XIV) 12420 N-(2-Aminoethyl)-N,N-diethylamine; N,N-Diethylethylene-diamine; N(1),N(1)-Diethyl-1,2-ethanediamine 100-36-7 C6H16N2 详情 详情
(XV) 53052 N-[2-(diethylamino)ethyl]-N-{[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl}amine; N~1~,N~1~-diethyl-N~2~-{[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl}-1,2-ethanediamine n/a C20H25F3N2 详情 详情

合成路线9

该中间体在本合成路线中的序号:(III)

The esterification of 4-formylcinnamic acid (I) with methanol and HCl gives the methyl ester (II), which can be obtained by Heck coupling of 4-bromobenzaldehyde (III) with methyl acrylate (IV). The reductocondensation of (II) with tryptamine (V) by means of NaBH(OAc)3 in dichloroethane yields the secondary amine (VI), which is alkylated with 2-(tert-butyldimethylsilyloxy)ethyl bromide (VII) by means of DIEA in DMSO to afford the tertiary amine (VIII). The reaction of the methyl ester group of (VIII) with KOH and hydroxylamine in methanol provides the silylated hydroxamic acid (IX), which is finally deprotected with TFA in water.

1 Perez, L.B.; Remiszewski, S.; Sambucetti, L.; et al.; Discovery and SAR of NVP-LAQ824, a novel histone deacetylase inhibitor with in vitro and in vivo antitumor activity. Proc Am Assoc Cancer Res 2002, 43, Abst 3671.
2 Bair, K.W.; Versace, R.W.; Green, M.A.; Remiszewski, S.W.; Perez, L.B.; Sambucetti, L.; Sharma, S.K. (Novartis AG; Novartis-Erfindungen VmbH); Deacetylase inhibitors. WO 0222577 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 55571 4-Formylcinnamic acid 23359-08-2 C10H8O3 详情 详情
(II) 46515 methyl (E)-3-(4-formylphenyl)-2-propenoate 7560-50-1 C11H10O3 详情 详情
(III) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(IV) 14156 methyl acrylate 96-33-3 C4H6O2 详情 详情
(V) 40537 Tryptamine; 2-(1H-Indol-3-yl)-1-ethanamine; 2-(1H-Indol-3-yl)ethylamine 61-54-1 C10H12N2 详情 详情
(VI) 55572 methyl 3-[4-({[2-(1H-indol-3-yl)ethyl]amino}methyl)phenyl]-2-propenoate C21H22N2O2 详情 详情
(VII) 55573 2-Bromoethoxy-t-butyldimethylsilane 86864-60-0 C8H19BrOSi 详情 详情
(VIII) 55574   C29H40N2O3Si 详情 详情
(IX) 55575 3-[4-({(2-{[(1,1-dimethylethyl)(dimethyl)silyl]oxy}ethyl)[2-(1H-indol-3-yl)ethyl]amino}methyl)phenyl]-N-hydroxy-2-propenamide C28H39N3O3Si 详情 详情

合成路线10

该中间体在本合成路线中的序号:(I)

 

1 Fassler A, Bold G, Capraro H, et aL 1996. Aza-peptide analogs as potent human immunodeficiency virus type-l protease inhibitors with oral bioavailability.JMed Cha;n, 39, 3203一3216
2 Fassler A, Bold G, Capraro H, et aL 1997. lruermediates Ior the prepantion of peptide analogues, W0 9746514
3 Giordano C, Pozzoli C, Benedetti F.2001. Ptocess for the pr帕嘣tion可8ryl-pyritlinyl compounds, W0 012083
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 22231 4-Bromobenzaldehyde 1122-91-4 C7H5BrO 详情 详情
(II) 23438 (4-bromophenyl)(methoxy)methyl methyl ether; 1-bromo-4-(dimethoxymethyl)benzene C9H11BrO2 详情 详情
(III) 29052 2-Bromopyridine;α-bromopyridine;α-bromoazine 109-04-6 C5H4BrN 详情 详情
(IV) 23440 4-(2-pyridinyl)benzaldehyde C12H9NO 详情 详情
(V) 10893 tert-butyl 1-hydrazinecarboxylate; tert-butyl carbazate 870-46-2 C5H12N2O2 详情 详情
(VI) 23442 tert-butyl 2-[(Z)-[4-(2-pyridinyl)phenyl]methylidene]-1-hydrazinecarboxylate C17H19N3O2 详情 详情
(VII) 23452 tert-butyl (1S)-1-benzyl-2-oxoethylcarbamate C14H19NO3 详情 详情
(VIII) 23444 tert-butyl (1S)-1-[(2R)oxiranyl]-2-phenylethylcarbamate C15H21NO3 详情 详情
(XXI) 66122 (2R,3R)-3-amino-4-phenyl-1-(1-(4-(pyridin-2-yl)benzyl)hydrazinyl)butan-2-ol trihydrochloride   C22H29Cl3N4O 详情 详情
(XXII) 66123 1,1,3,3-tetramethyl-2-(2-oxopiperidin-1-yl)isouronium tetrafluoroborate   C10H20F4N3O2 详情 详情
Extended Information